COMMUNIQUÉ DE PRESSE publié le 15/09/2025 à 07:29, il y a 2 mois 20 jours Ottobock plans Initial Public Offering in 2025 Ottobock SE & Co. KGaA plans an Initial Public Offering (IPO) in 2025, targeting EUR 100 million gross proceeds. The global MedTech leader in bionics is set to list on the Frankfurt Stock Exchange Frankfurt Stock Exchange IPO MedTech Ottobock Bionics
BRÈVE publiée le 21/08/2025 à 09:35, il y a 3 mois 14 jours Ottobock's Robust H1 2025 Results Driven by Innovation Innovation Revenue Growth EBITDA Increase Tech Investments Ottobock H1 2025
BRÈVE publiée le 21/08/2025 à 09:35, il y a 3 mois 14 jours Les solides résultats d'Ottobock au premier semestre 2025 sont portés par l'innovation Innovation Croissance Des Revenus Investissements Technologiques Augmentation De L'EBITDA Ottobock H1 2025
COMMUNIQUÉ DE PRESSE publié le 21/08/2025 à 09:30, il y a 3 mois 14 jours Ottobock with strong H1 2025 results: Innovation drives profitable growth Ottobock reports strong H1 2025 results with 5.0% revenue increase and 30.5% rise in underlying EBITDA, driven by innovation and strategic acquisitions Innovation MedTech Growth Ottobock H1 2025 Results
Publié le 04/12/2025 à 18:14, il y a 13 heures 41 minutes Résiliation d'une convention conclue entre actionnaires
Publié le 04/12/2025 à 18:00, il y a 13 heures 56 minutes Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Publié le 04/12/2025 à 18:00, il y a 13 heures 56 minutes Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Publié le 04/12/2025 à 17:45, il y a 14 heures 11 minutes Informations relatives au nombre total de droits de vote et d’actions
Publié le 04/12/2025 à 17:45, il y a 14 heures 11 minutes MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Publié le 05/12/2025 à 02:35, il y a 5 heures 21 minutes Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Publié le 05/12/2025 à 01:00, il y a 6 heures 56 minutes BEACN Closes First Tranche of Non-Brokered Private Placement
Publié le 04/12/2025 à 23:05, il y a 8 heures 51 minutes BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Publié le 04/12/2025 à 23:00, il y a 8 heures 56 minutes NXT Energy Solutions Completes Data Acquisition for SFD Survey
Publié le 05/12/2025 à 07:00, il y a 56 minutes Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Publié le 05/12/2025 à 03:30, il y a 4 heures 26 minutes CGTN: What makes cooperation between China and France a two-way success
Publié le 04/12/2025 à 23:50, il y a 8 heures 5 minutes EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Publié le 04/12/2025 à 20:25, il y a 11 heures 31 minutes Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Publié le 04/12/2025 à 20:15, il y a 11 heures 41 minutes Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
